Concepedia

Karen Lundgren

KL

32

Publications

3.8K

Citations

23

H-Index

1987

Active since

Affiliations

Biogen (United States)(Current)

Forma Therapeutics (United States)

Pfizer (United States)

Research Triangle Park Foundation

University of California, Irvine

Karen Lundgren is an author at Biogen (United States) specializing in medicine, natural sciences, and cell biology.

Top concepts

Publications per year

1987–2023

32

Publications

32

mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2

Karen Lundgren, Nancy C. Walworth, Robert Booher et al. · Cell · 1991 · 692 citations

, , +13

The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

Chad A. Dickey, Adeela Kamal, Karen Lundgren et al. · Journal of Clinical Investigation · 2007 · 628 citations · Full text

, , +19

Genomic instability in Gadd45a-deficient mice

M. Christine Hollander, M. Saeed Sheikh, Dmitry V. Bulavin et al. · Nature Genetics · 1999 · 516 citations

, , +4

Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

Karen Lundgren, Rosa Luna, Y B McNeill et al. · Genes & Development · 1997 · 237 citations · Full text

, , +13

Curvature of mouse satellite DNA and condensation of heterochromatin

Marko Radic, Karen Lundgren, Barbara A. Hamkalo · Cell · 1987 · 192 citations

, , +10

Rows per page

1–5 of 32